IART SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Integra LifeSciences Reports Third Quarter 2026 Financial Results and Provides Updated Guidance

Oct 21, 2026

8-K

Integra Announces Completion of Refinancing Transactions

Oct 19, 2026

8-K

Integra LifeSciences Announces Pricing of $450 Million of 9.500% Senior Secured Notes Due 2033

Oct 9, 2026

8-K

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance Following Cincinnati Facility Flooding

Oct 2, 2026

8-K

Integra LifeSciences Investor Presentation Highlights 2026 Operational Catalysts and Financial Performance

Sep 8, 2026

8-K

Integra LifeSciences Reports Second Quarter 2026 Financial Results

Jul 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

May 11, 2018

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

May 9, 2018

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Aug 5, 2015

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Aug 3, 2015

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Nov 7, 2013

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Nov 4, 2013

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 8, 2026

S-3ASR

February 2026 SHELF

Feb 26, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 31, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 4, 2024

S-3ASR

SHELF

Feb 22, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 27, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 5, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 6, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 4, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 4, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 25, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 6, 2023

Ownerships

TYPE

HEADLINE

FILED AT

Caruso Andrea B (Reporting)

Oct 13, 2026

Shinn Lesha R (Reporting)

Sep 28, 2026

Veillon-Berteloot Chantal (Reporting)

Sep 4, 2026

SCHEDULE 13G/A

PARADIGM CAPITAL MANAGEMENT INC/NY (Filed by)

Aug 13, 2026

SCHEDULE 13G

VANGUARD PORTFOLIO MANAGEMENT LLC (Filed by)

Jul 31, 2026

Mosebrook Jeffrey (Reporting)

Jul 6, 2026

Other

TYPE

HEADLINE

FILED AT

Integra LifeSciences Holdings Corporation IART · SEC Filings